Overnight Post-Exercise Recovery After Protein Ingestion Prior to Sleep

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT00991523
First received: October 6, 2009
Last updated: April 19, 2011
Last verified: April 2011

October 6, 2009
April 19, 2011
October 2009
August 2010   (final data collection date for primary outcome measure)
muscle protein synthesis [ Time Frame: 10 hours ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00991523 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Overnight Post-Exercise Recovery After Protein Ingestion Prior to Sleep
Protein Ingestion Prior to Sleep as a Dietary Strategy to Improve Post-exercise, Overnight Recovery.

The purpose of this study is to examine the effects of post-exercise protein ingestion prior to sleep on overnight protein kinetics and muscle recovery.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
  • Exercise
  • Resistance Training
  • Dietary Supplement: protein
    protein
  • Dietary Supplement: placebo
    placebo control
  • Experimental: sweetened beverage
    Intervention: Dietary Supplement: protein
  • Placebo Comparator: placebo control
    placebo
    Intervention: Dietary Supplement: placebo
Res PT, Groen B, Pennings B, Beelen M, Wallis GA, Gijsen AP, Senden JM, VAN Loon LJ. Protein ingestion before sleep improves postexercise overnight recovery. Med Sci Sports Exerc. 2012 Aug;44(8):1560-9. doi: 10.1249/MSS.0b013e31824cc363.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
24
December 2010
August 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male
  • Age between 20 and 30 years
  • Healthy, recreationally active
  • BMI <25 kg/m2

Exclusion Criteria:

  • Use of medication
Male
20 Years to 30 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
NCT00991523
MEC 09-3-054
Yes
Luc van Loon, University Hospital Maastricht
Maastricht University Medical Center
GlaxoSmithKline
Principal Investigator: Luc van Loon, PhD Maastricht University Medical Center
Maastricht University Medical Center
April 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP